GeneDx Holdings Corp. (WGS) Cash from operations

annual CFO:

-$28.50M+$151.65M(+84.18%)
December 31, 2024

Summary

  • As of today (September 10, 2025), WGS annual cash flow from operations is -$28.50 million, with the most recent change of +$151.65 million (+84.18%) on December 31, 2024.
  • During the last 3 years, WGS annual CFO has risen by +$161.94 million (+85.04%).
  • WGS annual CFO is now -52.16% below its all-time high of -$18.73 million, reached on December 1, 2019.

Performance

1-year change

+84.18%

3-year change

+85.04%

5-year change

-52.16%

15-year change

-52.16%

WGS Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

35.9%
WGS annual cash flow from operations is higher than 35.9% of companies in Healthcare sector

Range

All-time high

-$18.73M

3-year low

-$319.15M

Earnings dates

Last annual earnings report date

Dec 31, 2024
WGS previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
WGS next annual earnings announcement has not yet been scheduled

OtherWGScash flow metrics

annual CFI

-$30.13M
WGS annual cash flow from investing activities is -$30.13 million

annual CFF

$44.16M
WGS annual cash flow from financing activities is $44.16 million

annual FCF

-$33.99M
WGS annual free cash flow is -$33.99 million

annual CAPEX

$5.49M
WGS annual capital expenditures is $5.49 million

quarterly CFO:

$10.42M+$238.00K(+2.34%)
June 30, 2025

Summary

  • As of today (September 10, 2025), WGS quarterly cash flow from operations is $10.42 million, with the most recent change of +$238.00 thousand (+2.34%) on June 30, 2025.
  • Over the past year, WGS quarterly CFO has increased by +$14.93 million (+331.30%).
  • WGS quarterly CFO is now at all-time high.

Performance

3-month change

+2.34%

1-year change

+331.3%

3-year change

+112.31%

5-year change

-

WGS quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

79.63%
WGS quarterly cash flow from operations is higher than 79.63% of companies in Healthcare sector

Range

All-time high

$10.42M
WGS quarterly cash flow from operations is currently at an all-time high

3-year low

-$88.36M

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
WGS previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Oct 28, 2025
WGS next earnings announcement is scheduled for Oct 28, 2025

OtherWGScash flow metrics

quarterly CFI

-$36.35M
WGS quarterly cash flow from investing activities is -$36.35 million

quarterly CFF

$346.00K
WGS quarterly cash flow from financing activities is $346.00 thousand

quarterly FCF

$8.05M
WGS quarterly free cash flow is $8.05 million

quarterly CAPEX

$2.37M
WGS quarterly capital expenditures is $2.37 million

TTM CFO:

$13.02M+$14.93M(+785.11%)
June 30, 2025

Summary

  • As of today (September 10, 2025), WGS TTM cash flow from operations is $13.02 million, with the most recent change of +$14.93 million (+785.11%) on June 30, 2025.
  • Over the past year, WGS TTM CFO has increased by +$105.03 million (+114.16%).
  • WGS TTM CFO is now at all-time high.

Performance

3-month change

+785.11%

1-year change

+114.16%

3-year change

+104.5%

5-year change

-

WGS TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

77.05%
WGS TTM cash flow from operations is higher than 77.05% of companies in Healthcare sector

Range

All-time high

$13.02M
WGS TTM cash flow from operations is currently at an all-time high

3-year low

-$319.15M

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
WGS previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Oct 28, 2025
WGS next earnings announcement is scheduled for Oct 28, 2025

OtherWGScash flow metrics

TTM CFI

-$54.03M
WGS TTM cash flow from investing activities is -$54.03 million

TTM CFF

$59.05M
WGS TTM cash flow from financing activities is $59.05 million

TTM FCF

$830.00K
WGS TTM free cash flow is $830.00 thousand

TTM CAPEX

$12.19M
WGS TTM capital expenditures is $12.19 million

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

WGS Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+84.2%+331.3%+114.2%
3 y3 years+85.0%+112.3%+104.5%
5 y5 years-52.2%--

WGS Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+91.1%at high+111.8%at high+104.1%
5 y5-year-52.2%+91.1%at high+111.8%at high+104.1%
alltimeall time-52.2%+91.1%at high+111.8%at high+104.1%

WGS Cash from operations History

DateAnnualQuarterlyTTM
Jun 2025
-
$10.42M(+2.3%)
$13.02M(-785.1%)
Mar 2025
-
$10.18M(-419.9%)
-$1.90M(-93.3%)
Dec 2024
-$28.50M(-84.2%)
-$3.18M(-27.6%)
-$28.50M(-48.3%)
Sep 2024
-
-$4.39M(-2.4%)
-$55.17M(-40.0%)
Jun 2024
-
-$4.50M(-72.6%)
-$92.00M(-34.7%)
Mar 2024
-
-$16.41M(-45.0%)
-$141.00M(-21.7%)
Dec 2023
-$180.15M(-43.6%)
-$29.86M(-27.6%)
-$180.15M(-16.2%)
Sep 2023
-
-$41.23M(-22.9%)
-$214.94M(-18.0%)
Jun 2023
-
-$53.50M(-3.7%)
-$262.08M(-10.6%)
Mar 2023
-
-$55.56M(-14.1%)
-$293.22M(-8.1%)
DateAnnualQuarterlyTTM
Dec 2022
-$319.15M(+67.6%)
-$64.65M(-26.8%)
-$319.15M(+4.0%)
Sep 2022
-
-$88.36M(+4.4%)
-$307.02M(+6.0%)
Jun 2022
-
-$84.64M(+3.9%)
-$289.60M(+25.8%)
Mar 2022
-
-$81.49M(+55.2%)
-$230.26M(+20.6%)
Dec 2021
-$190.43M(+104.5%)
-
-
Dec 2021
-
-$52.52M(-26.0%)
-$190.97M(+21.8%)
Sep 2021
-
-$70.94M(+180.4%)
-$156.78M(+82.6%)
Jun 2021
-
-$25.30M(-40.1%)
-$85.84M(+41.8%)
Mar 2021
-
-$42.21M(+130.2%)
-$60.54M(+230.2%)
Dec 2020
-$93.13M(+397.3%)
-$18.33M
-$18.33M
Dec 2019
-$18.73M
-
-

FAQ

  • What is GeneDx Holdings Corp. annual cash flow from operations?
  • What is the all time high annual CFO for GeneDx Holdings Corp.?
  • What is GeneDx Holdings Corp. annual CFO year-on-year change?
  • What is GeneDx Holdings Corp. quarterly cash flow from operations?
  • What is the all time high quarterly CFO for GeneDx Holdings Corp.?
  • What is GeneDx Holdings Corp. quarterly CFO year-on-year change?
  • What is GeneDx Holdings Corp. TTM cash flow from operations?
  • What is the all time high TTM CFO for GeneDx Holdings Corp.?
  • What is GeneDx Holdings Corp. TTM CFO year-on-year change?

What is GeneDx Holdings Corp. annual cash flow from operations?

The current annual CFO of WGS is -$28.50M

What is the all time high annual CFO for GeneDx Holdings Corp.?

GeneDx Holdings Corp. all-time high annual cash flow from operations is -$18.73M

What is GeneDx Holdings Corp. annual CFO year-on-year change?

Over the past year, WGS annual cash flow from operations has changed by +$151.65M (+84.18%)

What is GeneDx Holdings Corp. quarterly cash flow from operations?

The current quarterly CFO of WGS is $10.42M

What is the all time high quarterly CFO for GeneDx Holdings Corp.?

GeneDx Holdings Corp. all-time high quarterly cash flow from operations is $10.42M

What is GeneDx Holdings Corp. quarterly CFO year-on-year change?

Over the past year, WGS quarterly cash flow from operations has changed by +$14.93M (+331.30%)

What is GeneDx Holdings Corp. TTM cash flow from operations?

The current TTM CFO of WGS is $13.02M

What is the all time high TTM CFO for GeneDx Holdings Corp.?

GeneDx Holdings Corp. all-time high TTM cash flow from operations is $13.02M

What is GeneDx Holdings Corp. TTM CFO year-on-year change?

Over the past year, WGS TTM cash flow from operations has changed by +$105.03M (+114.16%)
On this page